Satish Mehta is an Indian businessman, the founder and Chairman of generics maker Emcure Pharmaceuticals, headquartered in Pune. He started Emcure in 1981 as a contract manufacturer for multinationals, before expanding into selling his own branded generics.

After securing investments from private equity firms like Bain Capital, he listed the company on the Indian bourses in July 2024 at a 31% premium to the IPO price.

• Core Company: Emcure Pharmaceuticals, a major generics maker.
• Founding: Started Emcure in 1981.
• Family Governance: His daughter Namita (a judge on Shark Tank India) and son Samit are on the company's board.

Satish Mehta's career is defined by his successful pivot from a contract manufacturing model in 1981 to building a major generics maker that focuses on branded products. His structural contribution lies in scaling pharmaceutical production and distribution in India's competitive healthcare market.

The successful July 2024 IPO of Emcure, which secured a 31% premium, cemented his family's wealth. His children, Namita (Managing Director) and Samit, are now key directors, ensuring generational continuity.